Clinical Trial Update: Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating AEB071 in combination with tacrolimus (converted to mycophenolic acid after 3 months) for kidney transplant patients, focusing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• AEB071 (sotrastaurin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 1, Phase 2 | Status: COMPLETED